Bioimpacts

Papers
(The TQCC of Bioimpacts is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial83
A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines35
Cell cycle arrest and anti-cancer potential of probiotic Lactobacillus rhamnosus against HT-29 cancer cells31
Fluid-structure interaction of blood flow around a vein valve26
The active lung microbiota landscape of COVID-19 patients through the metatranscriptome data analysis22
Computational-based drug repurposing methods in COVID-1918
Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe disease16
Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems16
Global metabolomics profiling of colorectal cancer in Malaysian patients14
Improved antibacterial activity of topical gel-based on nanosponge carrier of cinnamon oil14
Characterization of isolated compounds from Morus spp. and their biological activity as anticancer molecules14
In silico approach towards the identification of potential inhibitors from Curcuma amada Roxb against H. pylori: ADMET screening and molecular docking studies12
Designing a new generation of expression toolkits for engineering of green microalgae; robust production of human interleukin-212
Melatonin increases 5-flurouracil-mediated apoptosis of colorectal cancer cells through enhancing oxidative stress and downregulating survivin and XIAP11
High efficacy of tamoxifen-loaded L-lysine coated magnetic iron oxide nanoparticles in cell cycle arrest and anti-cancer activity for breast cancer therapy10
Evaluating the presence of deregulated tumoral onco-microRNAs in serum-derived exosomes of gastric cancer patients as noninvasive diagnostic biomarkers10
Placenta mesenchymal stem cells differentiation toward neuronal-like cells on nanofibrous scaffold9
Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy9
COVID-19 pandemic may fuel academic bullying9
PLGA/TiO2 nanocomposite scaffolds for biomedical applications: fabrication, photocatalytic, and antibacterial properties9
Synthesis and characterization of actively HER-2 Targeted Fe3O4@Au nanoparticles for molecular radiosensitization of breast cancer9
Can early treatment of twitcher mice with high dose AAVrh10-GALC eliminate the need for BMT?9
Evaluation of in vitro antiplasmodial effect of extracts from seven medicinal plants used to treat malaria in Côte d'Ivoire.8
Relationship between endocrine disruptors and obesity with a focus on bisphenol A: a narrative review8
Injectable thermosensitive chitosan/gelatin hydrogel for dental pulp stem cells proliferation and differentiation8
Repair of rat cranial bone defect by using amniotic fluid-derived mesenchymal stem cells in polycaprolactone fibrous scaffolds and platelet-rich plasma7
Mesenchymal stromal cells therapy alone does not lead to the complete restoration of the skin parameters in diabetic foot patients within a 3-year follow-up period7
miR-1290 contributes to oncogenesis and angiogenesis via targeting of THBS1, DKK3 and, SCAI7
COVID-19 clinical implications: the significance of nanomedicine7
Fabrication, characterization, and optimization of a novel copper-incorporated chitosan/gelatin-based scaffold for bone tissue engineering applications6
A new strategy for the green synthesis of chondroitin sulfate-reduced gold nanoparticles; in vitro evaluation of synthesized nanoparticles6
A fuzzy logic-based computational method for the repurposing of drugs against COVID-196
COVID-19: Artificial sputum, respiratory obstruction method and screening of pyolitic and antihypoxic drugs6
Role of cellulose family in fibril organization of collagen for forming 3D cancer spheroids: In vitro and in silico approach6
Preparation and evaluation of a polycaprolactone/chitosan/propolis fibrous nanocomposite scaffold as a tissue engineering skin substitute6
Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy5
Classification and identification of human papillomavirus based on its prevalence and development of cervical lesion among Iranian women5
Intra-ovarian injection of bone marrow-derived c-Kit+ cells for ovarian rejuvenation in menopausal rats5
Function of arteries and veins in conditions of simulated cardiac arrest5
To detect potential pathways and target genes in infantile Pompe patients using computational analysis5
Molecular docking, molecular dynamics simulation, and ADMET analysis of levamisole derivatives against the SARS-CoV-2 main protease (MPro)5
PEGylated nanohydrogels delivering anti-MicroRNA-21 suppress ovarian tumor-associated angiogenesis in matrigel and chicken chorioallantoic membrane models5
Multi spectroscopic and molecular simulation studies of propyl acridone binding to calf thymus DNA in the presence of electromagnetic force5
The effects of concurrent treatment of silymarin and lactulose on memory changes in cirrhotic male rats5
Engineered nanoparticle bio-conjugates toxicity screening: The xCELLigence cells viability impact5
Silibinin exhibits anti-tumor effects in a breast cancer stem cell model by targeting stemness and induction of differentiation and apoptosis4
Therapeutic effects of bone marrow mesenchymal stem cells via modulation of TLR2 and TLR4 on renal ischemia-reperfusion injury in male Sprague-Dawley rats4
Nanoencapsulation of Hirudo medicinalis proteins in liposomes as a nanocarrier for inhibiting angiogenesis through targeting VEGFA in the Breast cancer cell line (MCF-7)4
SARS-CoV-2 and probable lung cancer risk4
Evaluation of in-situ gel-forming eye drop containing bacteriophage against Pseudomonas aeruginosa keratoconjunctivitis in vivo 4
0.037331104278564